FDA.reportPublic FDA data

belantamab mafodotin-blmf 70 MG Injection [Blenrep]

RxCUI
2725587
RxNorm name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Display name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Full name
belantamab mafodotin-blmf 70 MG Injection [Blenrep]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761440Blenrepbelantamab mafodotin-blmf351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BlenrepBELANTAMAB MAFODOTINGlaxoSmithKline LLCaef7c34c-fef8-407c-99c0-a68aded53c602025-10-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2725587

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aef7c34c-fef8-407c-99c0-a68aded53c60BLENREP 70 MG Injection [PSN] · belantamab mafodotin-blmf 70 MG Injection [Blenrep] [SBD] · Blenrep 70 MG Injection [SY]31These highlights do not include all the information needed to use BLENREP safely and effectively. See full prescribing information for BLENREP. BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use Initial U.S. Approval: 202020251023